CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 89 filers reported holding CARDIFF ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 2.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $114,000 | -65.2% | 74,020 | -50.5% | 0.01% | -57.1% |
| Q2 2022 | $328,000 | +20.1% | 149,494 | +35.4% | 0.01% | +40.0% |
| Q1 2022 | $273,000 | -31.6% | 110,394 | +66.3% | 0.01% | -28.6% |
| Q4 2021 | $399,000 | -9.7% | 66,394 | 0.0% | 0.01% | -26.3% |
| Q3 2021 | $442,000 | +97.3% | 66,394 | +96.9% | 0.02% | +111.1% |
| Q2 2021 | $224,000 | -51.6% | 33,713 | +30.9% | 0.01% | -50.0% |
| Q4 2020 | $463,000 | +9.5% | 25,755 | -13.9% | 0.02% | -10.0% |
| Q3 2020 | $423,000 | – | 29,900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,522,083 | $16,797,000 | 13.61% |
| Octagon Capital Advisors LP | 982,753 | $6,545,000 | 1.61% |
| Altium Capital Management LP | 348,888 | $2,324,000 | 0.61% |
| ACT CAPITAL MANAGEMENT, LLC | 102,500 | $683,000 | 0.35% |
| Eventide Asset Management | 1,670,399 | $11,125,000 | 0.15% |
| Artal Group S.A. | 750,000 | $4,995,000 | 0.11% |
| Virtus ETF Advisers LLC | 25,770 | $172,000 | 0.08% |
| HighVista Strategies LLC | 15,501 | $103,000 | 0.07% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 13,500 | $90,000 | 0.05% |
| SCHOLTZ & COMPANY, LLC | 16,625 | $111,000 | 0.04% |